Literature DB >> 200565

Detection of hepatitis A antigen by immunofluorescence.

L R Mathiesen, S M Feinstone, R H Purcell, J A Wagner.   

Abstract

Hepatitis A antigen (HA Ag) was demonstrated by immunofluorescence (IF) in liver biopsies from chimpanzees with experimental hepatitis A virus infection. Blocking experiments with paired sera from patients with hepatitis types A, B, or non-A, non-B, as well as with purified HA Ag, showed that the fluorescence was specific for HA Ag. HA Ag could be demonstrated only in biopsies from chimpanzees inoculated with hepatitis A virus. In two of four chimpanzees biopsied weekly, HA Ag could be detected by IF before stool shedding of HA Ag, elevation in serum alanine aminotransferase (SGPT), or histopathological evidence of liver disease was seen. The HA Ag was detected for 4 to 5 weeks; the last IF-positive biopsy was obtained after SGPT activity had returned to normal. In the two other chimpanzees, HA Ag could be detected only in the biopsy taken at the time of SGPT elevation. In the early IF-positive biopsies, HA Ag was diffusely distributed in the cytoplasm of many cells, but it later accumulated in a focal distribution in the cytoplasm of a few of the hepatocytes and Kupffer cells. This cytoplasmic distribution agrees with previous electron microscopic data.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200565      PMCID: PMC421263          DOI: 10.1128/iai.18.2.524-530.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  A DIALYSIS TECHNIQUE FOR PREPARING FLUORESCENT ANTIBODY.

Authors:  H F CLARK; C C SHEPARD
Journal:  Virology       Date:  1963-08       Impact factor: 3.616

2.  Antibodies to hepatitis A virus: patterns by two procedures.

Authors:  J Rakela; D Stevenson; V M Edwards; I Gordon; J W Mosley
Journal:  J Clin Microbiol       Date:  1977-01       Impact factor: 5.948

3.  Transmission of type B viral hepatitis to chimpanzees.

Authors:  L F Barker; F V Chisari; P P McGrath; D W Dalgard; R L Kirschstein; J D Almeida; T S Edington; D G Sharp; M R Peterson
Journal:  J Infect Dis       Date:  1973-06       Impact factor: 5.226

4.  Viral hepatitis. Clinical and tissue culture studies.

Authors:  J D Boggs; J L Melnick; M E Conrad; B F Felsher
Journal:  JAMA       Date:  1970-11-09       Impact factor: 56.272

5.  Liver cell surface localization of hepatitis B antigen and of immunoglobulins in acute and chronic hepatitis and in liver cirrhosis.

Authors:  A Alberti; G Realdi; F Tremolada; G P Spina
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

6.  A microtiter solid-phase radioimmunoassay for hepatitis A antigen and antibody.

Authors:  R H Purcell; D C Wong; Y Moritsugu; J L Dienstag; J A Routenberg; J D Boggs
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

7.  Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness.

Authors:  S M Feinstone; A Z Kapikian; R H Purceli
Journal:  Science       Date:  1973-12-07       Impact factor: 47.728

8.  Hepatitis in marmosets: induction of disease with coded specimens from a human volunteer study.

Authors:  A W Holmes; L Wolfe; H Rosenblate; F Deinhardt
Journal:  Science       Date:  1969-08-22       Impact factor: 47.728

9.  Intrahepatic expression of serum hepatitis virus-associated antigens.

Authors:  T S Edgington; D J Ritt
Journal:  J Exp Med       Date:  1971-10-01       Impact factor: 14.307

View more
  23 in total

1.  Mutations responsible for adaptation of hepatitis A virus to efficient growth in cell culture.

Authors:  S U Emerson; C McRill; B Rosenblum; S Feinstone; R H Purcell
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

2.  Mutations in both the 2B and 2C genes of hepatitis A virus are involved in adaptation to growth in cell culture.

Authors:  S U Emerson; Y K Huang; C McRill; M Lewis; R H Purcell
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

3.  Enzyme-linked immunosorbent assay for detection of hepatitis A antigen in stool and antibody to hepatitis A antigen in sera: comparison with solid-phase radioimmunoassay, immune electron microscopy, and immune adherence hemagglutination assay.

Authors:  L R Mathiesen; S M Feinstone; D C Wong; P Skinhoej; R H Purcell
Journal:  J Clin Microbiol       Date:  1978-02       Impact factor: 5.948

4.  Attenuation and cell culture adaptation of hepatitis A virus (HAV): a genetic analysis with HAV cDNA.

Authors:  J I Cohen; B Rosenblum; S M Feinstone; J Ticehurst; R H Purcell
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

5.  Detection of hepatitis A virus in seeded estuarine samples by hybridization with cDNA probes.

Authors:  X Jiang; M K Estes; T G Metcalf; J L Melnick
Journal:  Appl Environ Microbiol       Date:  1986-10       Impact factor: 4.792

6.  Immunofluorescence of hepatitis A virus antigen in chimpanzees.

Authors:  B L Murphy; J E Maynard; D W Bradley; J W Ebert; L R Mathiesen; R H Purcell
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

7.  PLC/PRF/5 (Alexander) hepatoma cell line: further characterization and studies of infectivity.

Authors:  R J Daemer; S M Feinstone; J J Alexander; J G Tully; W T London; D C Wong; R H Purcell
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

8.  Attenuated hepatitis A virus: genetic determinants of adaptation to growth in MRC-5 cells.

Authors:  A W Funkhouser; R H Purcell; E D'Hondt; S U Emerson
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

9.  In situ detection of hepatitis A virus in cell cultures and shellfish tissues.

Authors:  J L Romalde; M K Estes; G Szücs; R L Atmar; C M Woodley; T G Metcalf
Journal:  Appl Environ Microbiol       Date:  1994-06       Impact factor: 4.792

10.  Evaluation of urine as a clinical specimen for diagnosis of hepatitis a.

Authors:  Madhuri S Joshi; Shobha D Chitambar; Vidya A Arankalle; Mandeep S Chadha
Journal:  Clin Diagn Lab Immunol       Date:  2002-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.